Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared to usual care. The beneficial ...

Please provide your email address to receive an email when new articles are posted on . An updated guideline on the prevention and management of atrial fibrillation includes a new staging system to ...

Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

The RACE study compared the long-term effects of rate and rhythm control in patients with persistent atrial fibrillation (AF), concluding that both strategies were equally effective regarding ...

The increase in hospitalization risk seen with Vascepa was small vs the survival gains seen from decreased rates of heart attack, stroke, and revascularization, noted Deepak L. Bhatt, MD, MPH, Brigham ...

The risk for dementia goes up in patients with atrial fibrillation (AF), but some evidence suggests that risk can be blunted with therapies that restore sinus rhythm. But a new cohort study suggests ...

The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally ...